Native versus deglycosylated IgM in anti-MAG neuropathy: Correlation with clinical status - Study of 10 cases
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2019.577094
Abstract: BACKGROUND/PURPOSE In anti-myelin associated glycoprotein (anti-MAG) neuropathies, there is evidence that anti-MAG antibodies are pathogenic but numerous studies report the absence or a weak correlation between the titers of these antibodies and disease course. In… read more here.
Keywords: clinical status; mag; anti mag; mag neuropathy ... See more keywords
Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2017.04.015
Abstract: OBJECTIVE To identify factors associated with efficacy of rituximab (RTX) infusions in patients with anti-myelin associated glycoprotein (MAG) neuropathy. METHODS 33 patients with anti-MAG neuropathy treated with RTX were retrospectively evaluated. All patients underwent neurological,… read more here.
Keywords: predictive factors; efficacy rituximab; patients anti; anti mag ... See more keywords
Immunochemotherapy versus rituximab in anti-myelin-associated glycoprotein neuropathy: A report of 64 patients.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of haematology"
DOI: 10.1111/bjh.18202
Abstract: Monoclonal immunoglobulin M (IgM) anti-myelin-associated glycoprotein (MAG) neuropathy is a rare disabling condition, most commonly treated with rituximab monotherapy (R), which leads to neurological improvement in only 30%-50% of patients. The combination of rituximab plus… read more here.
Keywords: myelin associated; ict; anti myelin; mag neuropathy ... See more keywords
Prevalence, correlates and impact of pain and cramps in anti‐MAG neuropathy: a multicentre European study
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Neurology"
DOI: 10.1111/ene.13459
Abstract: The frequency of pain and cramps is uncertain in anti‐myelin associated glycoprotein antibody (anti‐MAG) neuropathy. Whether these symptoms may affect function/quality of life is unknown. read more here.
Keywords: anti mag; mag neuropathy; prevalence correlates; pain cramps ... See more keywords
Determinants of health‐related quality of life in anti‐MAG neuropathy: a cross‐sectional multicentre European study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the Peripheral Nervous System"
DOI: 10.1111/jns.12197
Abstract: Our objective was to assess determinants of quality of life (QoL) in anti‐myelin associated glycoprotein antibody (MAG) neuropathy. The SF‐36 questionnaire was assessed in 55 patients, from Marseille, Angers (France) and Birmingham (UK). Routine clinical… read more here.
Keywords: anti mag; mag neuropathy; quality life; score ... See more keywords
Nerve Hypertrophy and Altered Diffusion in Anti-Myelin-Associated Glycoprotein Neuropathy Detected by Brachial Plexus Magnetic Resonance Neurography.
Sign Up to like & getrecommendations! Published in 2021 at "European neurology"
DOI: 10.1159/000519128
Abstract: INTRODUCTION This study assessed the morphological changes and diffusion tensor imaging (DTI)-derived parameters of the brachial plexus using magnetic resonance neurography (MRN) in patients with anti-myelin-associated glycoprotein (anti-MAG) neuropathy. METHODS Eight patients with anti-MAG neuropathy… read more here.
Keywords: nerve hypertrophy; brachial plexus; anti mag; mag neuropathy ... See more keywords